Acumen Pharmaceuticals
ABOS
ABOS
50 hedge funds and large institutions have $278M invested in Acumen Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 12
6% more funds holding
Funds holding: 47 → 50 (+3)
5.27% more ownership
Funds ownership: 63.28% → 68.55% (+5.3%)
Holders
50
Holding in Top 10
2
Calls
$4.07M
Puts
$503K
Top Buyers
| 1 | +$11M | |
| 2 | +$6.81M | |
| 3 | +$5.73M | |
| 4 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$5.08M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$4.21M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$3.16M | |
| 3 | -$1.17M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$1.09M |
| 5 |
GPC
Guardian Point Capital
Charlottesville,
Virginia
|
-$1M |